Company Legal Name
Latest Valuation
Founded Year
Headquarter
Inception develops virtual event and video production tools specifically designed for audience engagement in life sciences events. The Fairfield-based company focuses on delivering specialized solutions that address the unique communication and presentation needs within the pharmaceutical, biotechnology, and medical device sectors. By concentrating on life sciences applications, Inception differentiates itself from generic virtual event platforms through industry-specific features and functionality. The company's platform enables organizations to conduct interactive scientific conferences, product launches, and educational sessions with enhanced audience participation capabilities. Inception continues to refine its technology stack to serve the evolving digital transformation requirements of life sciences organizations seeking effective virtual engagement solutions.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





